These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8988842

  • 21. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH, Wong BC, Lin MC, Zhu GH, Kung HF, Jiang SH, Yang D, Lam SK.
    Oncogene; 2001 Nov 29; 20(55):8009-18. PubMed ID: 11753684
    [Abstract] [Full Text] [Related]

  • 22. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 23. Expression of amphiregulin in human gastric cancer cell lines.
    Akagi M, Yokozaki H, Kitadai Y, Ito R, Yasui W, Haruma K, Kajiyama G, Tahara E.
    Cancer; 1995 Mar 15; 75(6 Suppl):1460-6. PubMed ID: 7889475
    [Abstract] [Full Text] [Related]

  • 24. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
    Liang H, O'Reilly S, Liu Y, Abounader R, Laterra J, Maher VM, McCormick JJ.
    Int J Oncol; 2004 May 15; 24(5):1057-67. PubMed ID: 15067326
    [Abstract] [Full Text] [Related]

  • 25. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript.
    Moghul A, Lin L, Beedle A, Kanbour-Shakir A, DeFrances MC, Liu Y, Zarnegar R.
    Oncogene; 1994 Jul 15; 9(7):2045-52. PubMed ID: 8208549
    [Abstract] [Full Text] [Related]

  • 26. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells.
    To C, Seiden I, Liu N, Wigle D, Tsao MS.
    Exp Cell Res; 2002 Feb 01; 273(1):45-53. PubMed ID: 11795945
    [Abstract] [Full Text] [Related]

  • 27. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
    Qiao H, Hung W, Tremblay E, Wojcik J, Gui J, Ho J, Klassen J, Campling B, Elliott B.
    J Cell Biochem; 2002 Feb 01; 86(4):665-77. PubMed ID: 12210733
    [Abstract] [Full Text] [Related]

  • 28. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
    Wang HL, Zhang SL, Lu YM, Jiang JY, Zhu XY.
    Ai Zheng; 2006 May 01; 25(5):570-5. PubMed ID: 16687076
    [Abstract] [Full Text] [Related]

  • 29. Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells.
    Wong AS, Leung PC, Auersperg N.
    Gynecol Oncol; 2000 Aug 01; 78(2):158-65. PubMed ID: 10926796
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. MAP kinase and beta-catenin signaling in HGF induced RPE migration.
    Liou GI, Matragoon S, Samuel S, Behzadian MA, Tsai NT, Gu X, Roon P, Hunt DM, Hunt RC, Caldwell RB, Marcus DM.
    Mol Vis; 2002 Dec 20; 8():483-93. PubMed ID: 12500177
    [Abstract] [Full Text] [Related]

  • 32. Involvement of hepatocyte growth factor in branching morphogenesis of murine salivary gland.
    Ikari T, Hiraki A, Seki K, Sugiura T, Matsumoto K, Shirasuna K.
    Dev Dyn; 2003 Oct 20; 228(2):173-84. PubMed ID: 14517989
    [Abstract] [Full Text] [Related]

  • 33. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M.
    Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539
    [Abstract] [Full Text] [Related]

  • 34. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH.
    Hepatology; 2002 Nov 01; 36(5):1089-97. PubMed ID: 12395318
    [Abstract] [Full Text] [Related]

  • 35. Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells.
    Welch WC, Kornblith PL, Michalopoulos GK, Petersen BE, Beedle A, Gollin SM, Goldfarb RH.
    Anticancer Res; 1999 Nov 01; 19(3A):1635-40. PubMed ID: 10470094
    [Abstract] [Full Text] [Related]

  • 36. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
    Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E.
    Hepatology; 1997 Mar 01; 25(3):619-23. PubMed ID: 9049208
    [Abstract] [Full Text] [Related]

  • 37. Expression of the Met/HGF receptor in normal and neoplastic human tissues.
    Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM.
    Oncogene; 1991 Nov 01; 6(11):1997-2003. PubMed ID: 1719465
    [Abstract] [Full Text] [Related]

  • 38. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells.
    Konturek PC, Kania J, Kukharsky V, Ocker S, Hahn EG, Konturek SJ.
    J Physiol Pharmacol; 2003 Mar 01; 54(1):17-32. PubMed ID: 12674216
    [Abstract] [Full Text] [Related]

  • 39. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H, Spee B, Ijzer J, Kik MJ, Penning LC, Kirpensteijn J.
    Vet Pathol; 2009 Sep 01; 46(5):869-77. PubMed ID: 19429984
    [Abstract] [Full Text] [Related]

  • 40. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer.
    Ebert M, Yokoyama M, Friess H, Büchler MW, Korc M.
    Cancer Res; 1994 Nov 15; 54(22):5775-8. PubMed ID: 7954397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.